BrainsWay Ltd.

Tel Aviv Stock Exchange:BWAY.TA

Sector

🏥 Health Care

Industries

🧠 Mental Health

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

Israel

Market Cap

USD 212.89 M

Share Price

USD 5.65

Avg Daily Volume

42,273

Change (1 day)

0.82%

Change (1 year)

83.94%

Change (YTD)

23.30%

BrainsWay Ltd. Total Assets for the year ending December 31, 2024: USD 94.32 M

BrainsWay Ltd. Total Assets is USD 94.32 M for the year ending December 31, 2024, a 49.77% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.

BrainsWay Ltd. Total Assets for the year ending December 31, 2023 was USD 62.97 M, a -2.33% change year over year.
BrainsWay Ltd. Total Assets for the year ending December 31, 2022 was USD 64.48 M, a -14.86% change year over year.
BrainsWay Ltd. Total Assets for the year ending December 31, 2021 was USD 75.73 M, a 122.67% change year over year.
BrainsWay Ltd. Total Assets for the year ending December 31, 2020 was USD 34.01 M, a -12.20% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Total Assets	Accounts Payable	Short-Term Debt	Long-Term Debt

Tel Aviv Stock Exchange: BWAY.TA

BrainsWay Ltd.

CEO	Mr. Hadar Levy
IPO Date	March 28, 2007
Location	Israel
Headquarters	Bynet Building
Employees	120
Sector	🏥 Health Care
Industries Mental Health 🧬 Biotechnology 🔬 Clinical Trials 💊 Pharmaceuticals

Description

Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.